Chu Q, Perrone F, Greillier L, Tu W, et al. Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. Lancet 2023;402:2295-2306.
PMID: 37931632